In this issue:
Breast reconstruction choice and body image
MRI before breast cancer surgery
Impact of surgery on survival in bone metastatic disease
Chemo outcomes after immediate breast reconstruction
Survival for patients who decline recommended treatment
Early breast cancer prognosis for 5 vs 2 years of adjuvant bisphosphonate
PET pathological response for de-escalating chemo in HER2+ early breast cancer
Intense vs tailored dosedense chemotherapy in high-risk early breast cancer
Celecoxib does not increase DFS
Supporting survivors via text messages
Please login below to download this issue (PDF)